Orphengesic Forte is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Galt Pharmaceuticals, Llc. The primary component is Orphenadrine Citrate; Aspirin; Caffeine.
Product ID | 61825-999_8bdbbced-c8b5-f95b-e053-2a95a90af3d3 |
NDC | 61825-999 |
Product Type | Human Prescription Drug |
Proprietary Name | Orphengesic Forte |
Generic Name | Orphenadrine Citrate, Aspirin And Caffeine |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2019-06-17 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA075141 |
Labeler Name | Galt Pharmaceuticals, LLC |
Substance Name | ORPHENADRINE CITRATE; ASPIRIN; CAFFEINE |
Active Ingredient Strength | 50 mg/1; mg/1; mg/1 |
Pharm Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC],Platelet Aggregation Inhibitor [EPC],Decreased Platelet Aggregation [PE],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-06-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA075141 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-06-17 |
Ingredient | Strength |
---|---|
ORPHENADRINE CITRATE | 50 mg/1 |
SPL SET ID: | 8f7380c4-2fec-4799-a883-a4dd91ceba57 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
Pharm Class PE | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
61825-302 | ORPHENGESIC FORTE | Orphenadrine Citrate, Aspirin and Caffeine |
61825-999 | Orphengesic Forte | Orphenadrine Citrate, Aspirin and Caffeine |
61825-305 | Norgesic | Orphenadrine Citrate, Aspirin and Caffeine |
50991-999 | Norgesic Forte | Orphenadrine Citrate, Aspirin and Caffeine |
21695-726 | Orphenadrine Citrate, Aspirin and Caffeine | Orphenadrine Citrate, Aspirin and Caffeine |
71993-304 | Orphenadrine Citrate, Aspirin and Caffeine | Orphenadrine Citrate, Aspirin and Caffeine |
71993-999 | Orphenadrine Citrate, Aspirin and Caffeine | Orphenadrine Citrate, Aspirin and Caffeine |
74157-999 | Orphenadrine Citrate, Aspirin and Caffeine | orphenadrine citrate, aspirin and caffeine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ORPHENGESIC FORTE 73689519 1491921 Dead/Cancelled |
PAR PHARMACEUTICAL, INC. 1987-10-13 |